Risk-tailored treatment of splenic marginal zone lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk-tailored treatment of splenic marginal zone lymphoma

Published:2021-08-16 Issue:1 Volume:33 Page:e36-e42
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Castelli Roberto,Balzarotti Monica,Salvi Emanuele,Simona Rossi Roberta,Lambertenghi Deliliers Giorgio,Bergamaschini Luigi,Gidaro Antonio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference66 articles.

1. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project.;Armitage;J Clin Oncol,1998

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.;Swerdlow;Blood

3. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.;Gebhart;Thromb Res,2014

4. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.;Zibellini;Haematologica,2010

5. High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency.;Castelli;Br J Haematol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP